Tiruvoipati R, Pandya H, Manktelow B, Smith J, Dodkins I, Elbourne D, Field D
Glenfield Hospital, Leicester, UK.
Arch Dis Child Fetal Neonatal Ed. 2008 Mar;93(2):F104-7. doi: 10.1136/adc.2006.113167. Epub 2007 Jun 26.
Extracorporeal membrane oxygenation (ECMO) remains the mainstay of management in neonates with severe but potentially reversible respiratory failure. In the UK, ECMO is available only as a supraregional service at four centres.
To explore regional variations in ECMO referrals and neonatal deaths due to severe respiratory failure in England, Wales and Northern Ireland.
In this retrospective study, data regarding ECMO referrals due to neonatal respiratory failure from January to December 2002 were obtained from the four UK ECMO centres and then subdivided according to the Government Office Regions. Anonymised data regarding neonatal deaths was obtained from Confidential Enquiry into Maternal and Child Health. Neonatal deaths were classified into four groups (group 1: deaths potentially avoidable by ECMO; group 2: deaths where it was unclear whether ECMO would have been of benefit; group 3: neonates not eligible for ECMO; and group 4: data inadequate to classify deaths).
There was significant regional variation in the rates of both ECMO referral (0.10 to 0.46 per 1000 live births; (p<0.001)) and neonatal deaths (groups 1 and 2) (0.09 to 0.32 per 1000 live births; (p<0.001)). Regions with high referral rates for ECMO tended towards having higher group 1 plus group 2 neonatal death rates (correlation coefficient = 0.75).
It is possible that there are significant regional variations in the uptake of ECMO and in neonatal mortality due to severe respiratory failure. A confidential prospective study may further clarify these observations and identify the factors that might lead to these variations.
体外膜肺氧合(ECMO)仍然是患有严重但可能可逆性呼吸衰竭的新生儿治疗的主要手段。在英国,ECMO仅在四个中心作为区域以上的服务提供。
探讨英格兰、威尔士和北爱尔兰ECMO转诊以及因严重呼吸衰竭导致的新生儿死亡的地区差异。
在这项回顾性研究中,2002年1月至12月因新生儿呼吸衰竭进行ECMO转诊的数据从英国四个ECMO中心获取,然后根据政府办公区域进行细分。关于新生儿死亡的匿名数据从孕产妇和儿童健康保密调查中获取。新生儿死亡分为四组(第1组:ECMO可能避免的死亡;第2组:不清楚ECMO是否有益的死亡;第3组:不符合ECMO条件的新生儿;第4组:数据不足以对死亡进行分类)。
ECMO转诊率(每1000例活产0.10至0.46例;(p<0.001))和新生儿死亡(第1组和第2组)率(每1000例活产0.09至0.32例;(p<0.001))均存在显著的地区差异。ECMO转诊率高的地区往往第1组加第2组新生儿死亡率也较高(相关系数 = 0.75)。
ECMO的使用以及因严重呼吸衰竭导致的新生儿死亡率可能存在显著的地区差异。一项保密的前瞻性研究可能会进一步阐明这些观察结果,并确定可能导致这些差异的因素。